Alert: New Earnings Report (8/1/24)-Ultragenyx Pharmaceutical Inc (NASDAQ: RARE).
Ultragenyx Pharmaceutical Inc (NASDAQ: RARE) has reported a loss for its second fiscal quarter (ending June 30) of $-1.52 versus a loss $-2.25 for the same period a year ago. For the latest four quarters […]